Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation
Pharmaceutical Science Advances · 2026-12 · 4 · 100119
DOI: 10.1016/j.pscia.2026.100119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Yasser Fakri Mustafa. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, Iraq.
Zitieren
APA
Mustafa, Y. F. (2026). Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation. Pharmaceutical Science Advances, 4, 100119. https://doi.org/10.1016/j.pscia.2026.100119
Vancouver
Mustafa YF. Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation. Pharmaceutical Science Advances. 2026;4:100119. doi:10.1016/j.pscia.2026.100119
BibTeX
@article{Mustafa2026,
author = {Mustafa, Yasser Fakri},
title = {Artificial intelligence-driven discovery of coumarin-based therapeutics: Revolutionizing target identification and validation},
journal = {Pharmaceutical Science Advances},
year = {2026},
volume = {4},
pages = {100119},
doi = {10.1016/j.pscia.2026.100119}
}
EUVIMED